Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron oxide particulate matter
August 17, 2016 17:44 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10 g (NDC...
Sagent Pharmaceuticals Announces the Launch of Amikacin Sulfate Injection, USP
July 18, 2016 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 18, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced the launch of Amikacin Sulfate Injection, USP, an anti-infective/antibiotic, in ...
Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd.
June 16, 2016 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., June 16, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leading provider of affordable pharmaceuticals to the hospital market, today announced that it has...
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Dark Particulate Matter
June 13, 2016 17:51 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., June 13, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10g (NDC 25021-163-69)...
Sagent Pharmaceuticals Reports First Quarter 2016 Financial Results
May 03, 2016 07:30 ET
|
Sagent Pharmaceuticals, Inc.
Company Affirms 2016 Full Year Guidance Substantial Progress against Long-Term Growth Strategy; SCHAUMBURG, Ill., May 03, 2016 (GLOBE NEWSWIRE) --...
Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2016 Financial Results
April 25, 2016 09:07 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., April 25, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, today announced that it will...
Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
March 23, 2016 16:05 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., March 23, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, announced the hiring of Sean...
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg Per 100mL Due to the Discovery of an Out of Specification Impurity Result Detected During Routine Quality Testing of Stability Samples at the 18-Month Interval
March 01, 2016 12:30 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., March 01, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Fluconazole Injection, USP, (in 0.9% Sodium Chloride)...
Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
February 25, 2016 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leading provider of affordable pharmaceuticals to the hospital market, announced the hiring of...
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results
February 16, 2016 07:30 ET
|
Sagent Pharmaceuticals, Inc.
Establishes Long-Term Growth Strategy to Expand Product Offerings, Enhance Operational Performance, and Execute on Strategic Acquisitions Enters Into Agreement to Sell Sagent (China) Pharmaceuticals...